- Source type
- Government
- Access type
- Official
- Publisher
- U.S. Food and Drug Administration
- Date
- 2026-07-01
- Added
- 2026-07-05
Trust profile
VV Source Trust Matrix v1.0
VV Source Trust Matrix v1.0 asks whether this source is trustworthy for the claim lane being used, not whether every possible claim from it is equally strong.
94
U.S. health regulator
- Publisher type
- Regulator
- Bias profile
- Low
This source is strongest for regulatory status and safety and weaker for consumer context and trial discovery.
VV Source Fit Score 1.0
Fit by use case
Fit scores are role-specific. A source can be excellent for one claim lane and weak for another.
- Regulatory status
- 98/100
- Primary Anchor
- Clinical outcomes
- 84/100
- Strong Support
- Mechanism
- 68/100
- Context Source
- Safety
- 95/100
- Primary Anchor
- Consumer context
- 68/100
- Context Source
- Trial discovery
- 68/100
- Context Source
Best used for
- Approvals
- Labels
- Safety communications
Weak for
- Comparative effectiveness
- Consumer experience
Used in Viral Vitalism
FDA Extended the Only U.S.-Licensed Coral Snake Antivenin Lot
Roles: Primary source
Related studies
No structured study record is currently attached to this source.
Related sources
DailyMed: North American coral snake antivenin label
Regulatory-label context for North American coral snake antivenin.
- Trust score
- 94
- Publisher
- DailyMed / National Library of Medicine
- Access
- Official
- Usage
- 1 connection
FDA: Casgevy expanded to young children with sickle cell disease
Primary regulatory source for the July 2026 Casgevy age-expansion brief.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 1 connection
AABB: FDA warns against use of unapproved HCT/Ps
Canonicalized from June 30, 2026 rapid-brief batch.
- Trust score
- 91
- Publisher
- AABB
- Access
- Publisher
- Usage
- 1 connection
CDC: About Community Water Fluoridation
Government public-health source for community water fluoridation benefits, recommended concentration context, dental equity framing, and CDC’s current population-level cavity-prevention position.
- Trust score
- 91
- Publisher
- Centers for Disease Control and Prevention
- Access
- Official
- Usage
- 13 connections
CMS: Medicare GLP-1 Bridge launch announcement
Primary CMS source for the temporary Medicare GLP-1 Bridge access program.
- Trust score
- 91
- Publisher
- Centers for Medicare & Medicaid Services
- Access
- Official
- Usage
- 1 connection
FDA Q&A: Proposed order for over-the-counter sunscreen
U.S. Food and Drug Administration used across the Viral Vitalism evidence library.
- Trust score
- 94
- Publisher
- U.S. Food and Drug Administration
- Access
- Official
- Usage
- 9 connections